1 / 36

Liability Storms and How to Quantify Their Effect

Liability Storms and How to Quantify Their Effect. Casualty Actuarial Society Seminar on Ratemaking March 27, 2003 William R. Azzara Gail Ross, FCAS, MAAA. Outline. Overview of Liability Exposures Reasons to be Proactive and Quantify A Method to Use. Asbestos Pollution Lead Phen-Fen

dacian
Download Presentation

Liability Storms and How to Quantify Their Effect

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Liability Storms and How to Quantify Their Effect Casualty Actuarial Society Seminar on Ratemaking March 27, 2003 William R. Azzara Gail Ross, FCAS, MAAA

  2. Outline • Overview of Liability Exposures • Reasons to be Proactive and Quantify • A Method to Use

  3. Asbestos Pollution Lead Phen-Fen Construction Defect Toxic Mold Tobacco Alcohol Firearms Latex Sensitivity MTBE Liability Exposures

  4. Pollution – Estimates are Stable • Slow growth in number of sites on the National Priority List • No dramatic changes in coverage case precedents, thereby encouraging settlements • Ongoing settlement activity has stabilized payment levels • Risk based corrective action has resulted in lower clean-up costs than originally expected by EPA • Greater PRP participation in site remediation – incentive to reduce / control costs

  5. Pollution – Net U.S. Estimates • A.M. Best’s estimate of ultimate losses & ALAE = $56 billion • More recent estimates from other sources have been lowered to $30-$40 billion • A.M. Best believes that its estimate is still reasonably accurate, if not somewhat on the conservative side.

  6. Phen-Fen • Diet drug manufactured by American Home Products (now Wyeth) • Serious health problems allegedly caused by product (e.g. heart valve and often fatal lung condition) • Wyeth settled large class for $3.5 billion but claims continue to be received • Wyeth recently added $910 million to its Phen-Fen reserve bringing total to $14+ billion

  7. Construction Defect (CD) • “If you build it, they will sue” • Claims allegedly caused by negligence in the construction process • General construction • Toxic Mold • EIFS/Synthetic stucco • Claims have resulted in changes in practices by insurers • Pulling out of states • Eliminating classes of business

  8. Toxic Mold • High profile exposure to industry is primarily due to First Party Coverages • Homeowners, Commercial Property, WC • Recent CA case resulting in $18 million in punitive damages in direct action against HO carrier • Limited claim activity from Third Party Coverages • If liability emerges in future, will the Pollution Exclusion apply? • Fitch recently concluded “Mold is not the next asbestos”

  9. Tobacco • Significant claim activity for manufacturers • Some for distributors, advertisers, suppliers • Types of exposures include • Private lawsuits • Reimbursement actions • Government recovery of medical costs • Private reimbursement actions • Class Action suits have been certified

  10. Tobacco • State medical cost recovery actions • Settlement of 46 states Medicaid actions • Payment of at least $206 billion • Includes changes in business practices • Voluntary settlement did not remove potential for future liability • Note recent CA verdicts of $28 billion and $3 billion respectively for two individual claimants • Insurance industry exposure remains uncertain

  11. Tobacco • Foreign Exposure • Canada has several reimbursement actions pending (Quebec suing for $200 million) • EU, Colombia, Guatemala, Israel and others have also filed actions (Spain has first European local government action) • Australian market faces large class action suit • There may be no operable exclusions

  12. Lead • Contamination from lead paint & plumbing • Primary defendants include: • Building owners • Paint and pigment manufacturers or distributors • Plumbing manufacturers and distributors • Plaintiffs include government agencies and building tenants

  13. Lead • Frequency of claims has been less than the industry’s initial expectations • Plaintiffs have failed in certifying class actions • Landmark RI suit against lead paint industry recently ended in mistrial • Similar litigation filed by Chicago, Milwaukee, St. Louis & counties in TX and CA • Additional litigation possible in CT, WV, NJ, MA, NH and OH • Concern that Market Share Distribution of liability could result in significant costs • Lead paint remains in 330,000 private homes and public buildings in RI alone

  14. Alcohol • Types of claimants: • Consumers of alcoholic beverages • Third parties injured by alcohol consumers • Victims of FAS (fetal alcohol syndrome) • Government agencies and health care providers who provide care for alcohol related injuries

  15. Alcohol • Alcohol industry has successfully defended itself against all alcohol consumption suits, to date • Concern over products liability exposure similar to asbestos • No apparent contract exclusions • However, product warnings do exist

  16. Firearms • Products Liability actions are a recent phenomenon • Lawsuits include: • Private and public recovery actions modeled after government’s efforts against the tobacco industry • Against defendants that include: • Manufacturers • Retailers and Resellers • Firearms Trade Associations

  17. Firearms • Difficult to predict insurance implications due to recent activity • Several manufacturers have placed their carriers on notice • There are generally no specific applicable exclusions • Market Share Distribution of liability remains speculative but of concern for industry • Plaintiffs are watching a Brooklyn case in which it is alleged that manufacturers did nothing to prevent product misuse • Public appeal to have bullet shell “fingerprinting” by manufacturer

  18. Latex Sensitivity • About 2.5% of the population is sensitive to the proteins contained in latex • Increased demand due to AIDS led to higher levels of protein in gloves • Hyper-sensitivity can cause skin and respiratory reactions leading to disability or death

  19. Latex Sensitivity • Types of Claimants include: • Healthcare workers • Patients • The potential impact to the insurance industry appears manageable • Courts have generally frustrated the plaintiff bar’s attempts to certify class actions • Most courts now address product identification before allowing additional discovery

  20. Methyl Tertiary Butyl Ether (MTBE) • Gasoline additive used as anti-knock compound (1979) and to improve combustion and reduce CO emissions (1992) • 1995 – mandatory “Reformulated Gasoline” use results in 30% of nationwide gasoline sales contain MTBE • Use of MTBE will stop in 2003-CA to delay • Identified as a possible carcinogen

  21. MTBE • Alleged groundwater contamination from petroleum containing MTBE • Non-specific symptoms may lead to claims • Pollution exclusion may not apply (Products Liability) • Government’s virtual mandate of use will likely be used as a defense • Recent jury verdict against refiners in Lake Tahoe drinking water contamination

  22. Advertising Injury / Intellectual Property Genetically Modified Crops Managed Care SV-40 Other Developing Exposures

  23. The Problem • Industry estimates of liability from latent exposures are significantly higher than the sum of amounts disclosed by companies • Some companies: • Are slow to identify/quantify latent exposures • Are under-reserved • Have elected the business strategy of recognizing the liabilities as claims develop

  24. The Problem • Quantitative Effects • Immediate and direct effect on current earnings and equity/surplus of reflecting liability • Uncertainty of future earnings drag if future costs exceed established reserve • Qualitative Effects • Management abilities questioned • Mergers & Acquisitions limited by uncertainty

  25. What is Needed • Identification of Exposure • Coverages that might result in exposure • Time span coverage was afforded • Quantify Ultimate Cost • Potential frequency • Potential severity • Timing of future claim filings & payments • Potential defense costs

  26. Method to Quantify • Determine a company’s Latent Loss Liability using: • Company’s own data • Claim Specialists with working knowledge of Latent Liability Losses • Industry-wide data

  27. Method to Quantify • Management Interviews • Detailed Claim File Review to determine Amount and Timing of Losses • Actuarial Projections using Company Specific and Industry data to estimate IBNR • Reinsurance Considerations

  28. Method – File Selection • Target Claims selected for review based on: • Current reserve size • Presence of Declaratory Judgment (DJ) reserves • Defendant name recognition • Loss Type – Asbestos, Pollution, etc. • Claim Status – Open, Closed, Re-open • Year – Accident, Policy, or Underwriting • Random Claims – selected from remaining population

  29. Method – File Review • Detailed Claim File Reviews • End-of-Day Ultimate Losses are estimated on a claim-by-claim basis for Target and Random Claims • Ultimate Losses are based on Industry Experience and the working knowledge of claim specialists

  30. Method – File Review • Detailed Claim File Reviews (cont’d) • Ultimate Losses include provisions for: • Loss • Loss Expense • DJ Expense • Expected Timing of Claim Payments

  31. Method – IBNR Estimate • Provision for IBNR (Incurred But Not Reported) is split into two components: • IBNER – Incurred But Not Enough Reported • Additional amount of reserve for known and unknown claims involving known insureds, known contracts and known/reported claim types • IBNYR – Incurred But Not Yet Reported • Provision for unreported claims involving unknown insureds and unknown contracts for known claim types

  32. Method – IBNER Estimate • Estimate utilizes the results of: • Target Claims file review • Random Claims file review • Loading for remaining claims based on Random Claim file review • Average Ultimate Loss estimate is extrapolated over the Non-Target Claims to develop an estimate of Ultimate Losses for this group

  33. Method – IBNYR Estimate • Provision for IBNYR Losses based on: • Industry estimates of Ultimate Losses • Claim Specialists’ estimate of “stage of development” for the particular book • “Traditional” Actuarial Approaches • Survival Ratios • Market Share Evaluation

  34. Method – Reinsurance • Using a sample of claim files, the relationship of reinsurance to direct/gross liabilities is determined • Intended vs. collected cessions • Based on these relationships, any ceded reinsurance liabilities are determined • How much uncollectible reinsurance?

  35. Advantages of Method • Analysis performed at claim level • Source of exposure and differences in claim estimates can be pinpointed to specific types of claims, claimants, policies, etc. • Uses fewer global assumptions • Can more effectively quantify the qualitative aspects and uniqueness of the book

  36. Advantages of Method • Claim Specialists perform a large part of the review • Hands-on experience enables more accurate estimate of potential exposure by tailoring analysis to specific factual damage and coverage information involved at claim level • Specific consideration of development stage and timing • Actuaries are involved where global assumptions are made

More Related